Irish journal of medical science · 2026
Intraoperative methylene blue administration and postoperative delirium: a meta-analysis of surgical patients.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Taylan Seçil, Küçükakça Çelik Gülden, Gezer Derya
Аннотация
BACKGROUND: This meta-analysis aimed to determine the effect of intraoperative intravenous methylene blue administration on the incidence of postoperative delirium in adult surgical patients.
METHODS: This systematic review and meta-analysis was reported in accordance with PRISMA guidelines and registered in PROSPERO. A comprehensive search of seven electronic databases was performed from inception to January 2026 to identify randomized controlled trials evaluating intraoperative intravenous methylene blue administration and postoperative delirium in adult surgical populations. Study selection, data extraction, and methodological quality assessment were independently conducted by two reviewers using predefined eligibility criteria. Risk of bias was assessed using the Cochrane Risk of Bias 2 tool. Pooled odds ratios with 95% confidence intervals were calculated using a fixed-effect model due to the absence of between-study heterogeneity. Publication bias was evaluated using funnel plot inspection, Egger's regression test, and Kendall's tau test.
RESULTS: Three randomized controlled trials involving 779 patients were included. Intraoperative methylene blue administration was associated with a statistically significant reduction in postoperative delirium (OR = 0.35; 95% CI: 0.23-0.53; I2 = 0%).
CONCLUSIONS: Intraoperative methylene blue administration was associated with a reduction in postoperative delirium in surgical patients. However, given the limited number of included studies, further large-scale randomized controlled trials are required.
METHODS: This systematic review and meta-analysis was reported in accordance with PRISMA guidelines and registered in PROSPERO. A comprehensive search of seven electronic databases was performed from inception to January 2026 to identify randomized controlled trials evaluating intraoperative intravenous methylene blue administration and postoperative delirium in adult surgical populations. Study selection, data extraction, and methodological quality assessment were independently conducted by two reviewers using predefined eligibility criteria. Risk of bias was assessed using the Cochrane Risk of Bias 2 tool. Pooled odds ratios with 95% confidence intervals were calculated using a fixed-effect model due to the absence of between-study heterogeneity. Publication bias was evaluated using funnel plot inspection, Egger's regression test, and Kendall's tau test.
RESULTS: Three randomized controlled trials involving 779 patients were included. Intraoperative methylene blue administration was associated with a statistically significant reduction in postoperative delirium (OR = 0.35; 95% CI: 0.23-0.53; I2 = 0%).
CONCLUSIONS: Intraoperative methylene blue administration was associated with a reduction in postoperative delirium in surgical patients. However, given the limited number of included studies, further large-scale randomized controlled trials are required.